The PITT-RCSI PhD Program in Precision and Regenerative Medicine (PRM) is an innovative, research-based international program designed to create new knowledge at the forefront of an emerging biomedical field. As a joint initiative between the University of Pittsburgh and the Royal College of Surgeons in Ireland (RCSI) in Dublin, this is the first program at Pitt where a dual PhD degree is awarded by two international institutions. The program will be managed by various committees (Steering Committee, Curriculum Committee, Admissions Committee and Milestones Committee) consisting of equal number of faculty from both institutions.
The PhD Program in Precision and Regenerative Medicine (PRM) is a research-intensive dual doctoral program that advances discovery at the forefront of precision and regenerative medicine—an emerging and transformative field in biomedical science. The program provides an outstanding graduate training environment designed to prepare highly motivated PhD students to address complex challenges in human health through interdisciplinary research. Students have two thesis advisors, one each at Pitt and RCSI, and work on a joint collaborative research project. Students will spend their first year of graduate study at Pitt taking courses and doing rotations in three laboratories (on joint projects with RCSI faculty). At the end of first year, approximately half of the students will continue their research in a Pitt laboratory while the rest will move to conduct research in an RCSI lab. At the end of approximately two years, students will switch to institutions and continue their thesis research in collaborators’ laboratories. By conducting research on two continents and immersing themselves in diverse environments, graduates are prepared for high-level positions in academia, pharmaceutical industry, and regulatory agencies, among others.
EXPLORE Precision and regenerative medicine faculty